Global Hadron Therapy 2019 Market Share, Trends, Segmentation and Forecast to 2025
MarketResearchNest.com adds “Global Hadron Therapy Market Professional Survey Report 2019”new report to its research database. The report spread across 105 pages with multiple tables and figures in it.
Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
The global Hadron Therapy market was valued at – million US$ in 2018 and will reach – million US$ by the end of 2025, growing at a CAGR of -% during 2019-2025.
Request a sample copy at
https://www.marketresearchnest.com/report/requestsample/740825
This report focuses on Hadron Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hadron Therapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hadron Therapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hadron Therapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
- Koninklijke Philips N.V.
- Advanced Oncotherapy
- Varian Medical Systems
- Optivus Proton Therapy
- Hitachi, Ltd.
- Mevion Medical Systems
- ProTom International
- Mitsubishi Electric Corporation
- Sumitomo Corporation
- ProNova Solutions, LLC
Segment by Regions
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
Browse detail report with in-depth TOC at
https://www.marketresearchnest.com/Global-Hadron-Therapy-Market-Professional-Survey-Report-2019.html
Hadron Therapy in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. A Hadron Therapy Market provides an extensive view of size; trends and shape have been developed in this report to identify factors that will exhibit a significant impact in boosting the sales of Hadron Therapy Market in the near future.
Segment by Type
- Electron Beam
- Proton Beam
- Neutron Beam
- Carbon Ion Beam
- Alpha Particle Beam
- Beta Particle Beam
Segment by Application
- Pediatric Cancer
- Bone and Soft Tissue Cancer
- Prostate Cancer
- Lung Cancer
- Liver Cancer
- Eye Cancer
- Head and Neck Cancer
- Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
The research report provides in-depth analysis on:
- The estimated growth rate along with size and share of the Hadron Therapy Market during the forecast period.
- The prime factors expected to drive the Hadron Therapy Market for the estimated period.
- The major market leaders and what has been their business winning strategy for success so far.
- Significant trends shaping the growth prospects of the Hadron Therapy Market.
Purchase a Report copy at
https://www.marketresearchnest.com/report/purchase/740825
About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.
Contact Us
Mr. Jeet Jain
Sales Manager
+91-888-841-3131(IND) | +1-240-284-8070(U.S) | +44-20-3290-4151(U.K)
